Synergistic induction of tissue-type plasminogen activator expression by retinoids and cyclic nucleotides in rat C6 glioma cells

Fibrinolysis and Proteolysis

Volumn 12, Issue 2, 1998, Pages 71-78

  Pernod, G ^a   Aouffen, M ^a   Polack, B ^a   Le Magueresse Battistoni, B ^b   Benabid, A L ^a   Kolodie L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE; RETINOID; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ARTICLE; CROSS LINKING; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; GENE EXPRESSION REGULATION; GLIOMA CELL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; RAT;

EID: 0031747450     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80379-2     Document Type: Article

References (47)

1. Berenbaum M C. Synergy, additivism and antagonism in immunosuppression. Clin Exp Immunol 1977; 28: 1-18.
2. Seeds N W, Verrall S, Friedman G, et al. Plasminogen activators and plasminogen activator inhibitors in neural development. Ann N Y Acad Sci 1992; 667: 32-40.
3. Sumi Y, Dent MAR, Owen D E, Seeley P J, Morris R J. The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neural growth. Development 1992; 116: 625-637.
4. Murphy P G, Hart D A. Regulation of plasminogen activators and plasminogen activator inhibitor expression by cells of neural origin. Sem Thromb Hemost 1991; 17: 268-275.
5. Benjamin L A, McGarry R C, Hart D A. Effect of retinoic acid on human neuroblastoma. Cancer Chemother Pharmacol 1989; 25: 25-31.
6. Pernod G, Amalfitano G, Le Magueresse B, Berger F, Polack B, Kolodié L. Retinoids induce t-PA synthesis by C6 glioma cells -Role in tumoral haemorrhagic necrosis. Thromb Haemost 1996; 75: 332-338.
7. Chambon P. The molecular and genetic dissection of the retinoid signalling pathway. Gene 1993; 135: 223-228.
8. Bulens F, Ibanez-Tallon I, Van Acker P, De Vriese A, Nelles L, Belayew A, Collen D. Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases. J Biol Chem 1995; 270: 7167-7175.
9. Bulens F, Merchiers P, Ibanez-Tallon I, et al. Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator gene. J Biol Chem 1997; 272: 663-671.
10. Kooistra T, Lansink M, Arts J, Sitter T, Toet K. Involvement of retinoic acid receptor a in the stimulation of tissue-type plasminogen activator gene expression in human endothelial cells. Eur J Biochem 1995; 232: 425-432.
11. Lansink M, Kooistra T. Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor β2 induction. Blood 1996; 88: 531-541.
12. Ohlsson M, Leonardsson G, Jia X C, Feng P, Ny T. Transcriptional regulation of the rat tissue-type plasminogen activator gene: localisation of DNA elements and nuclear factors mediating constitutive and cyclic AMP-induced expression. Mol Cell Biol 1993; 13: 266-275.
13. Arts J, Herr I, Lansink M, Angel P, Kooistra T. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and Hela cells in vivo and in vitro. Nucl Acids Res 1997; 25: 311-317
14. Kurie J M, Younes A, Miller W H, et al. Retinoic acid stimulates the protein kinase C pathway before activation of its β-nuclear receptor during human teratocarcinoma differentiation. Biochim Biophys Acta 1993; 1179: 203-207
15. Medh R D, Santell L, Levin E G. Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation. Blood 1992; 80: 981-987.
16. Rickles RJ, Darrow A L, Strickland S. Molecular cloning and complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem 1988; 263: 1563-1569.
17. Galvin-Parton P A, Watkins D C, Malbon C C. Retinoic acid modulation of transmembrane signalling. J Biol Chem 1990; 265: 17771-17779.
18. Ludwig K W, Lowey B, Niles R M. Retinoic acid increases cyclic AMP-dependent protein kinase activity in murine melanoma cells. J Biol Chem 1980; 255: 5999-6002.
19. Plet A, Evain D. Effect of retinoic acid treatment of F9 embryonal carcinoma cells on the activity and distribution of cyclic AMP-dependent protein kinase. J Biol Chem 1982; 257: 889-893.
20. Fontana J A, Emler C, Ku K, McClung J K, Butcher F R, Durham J P. Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukaemia (HL60) cells induced to differentiate by retinoic acid. J Cell Physiol 1984; 120: 49-60.
21. Huggenvik J I, Collard M W, Kim Y W, Sharma R P. Modification of the retinoic acid signalling pathway by the catalytic subunit of protein kinase A. Mol Endocrinol 1993; 7: 543-550.
22. Davis K D, Lazar M A. Induction of retinoic acid receptor-β by retinoic acid is cell specific. Endocrinology 1993; 132: 1469-1474.
23. Holmberg M, Leonardsson G, Ny T. The species-specific differences in the cAMP regulation of the tissue-type plasminogen activator gene between rat, mouse and human is caused by a one-nucleotide substitution in the cAMP-responsive element of the promoters. Eur J Biochem 1995; 231: 466-474.
24. Chomczinski P, Sacchi N. Single-step method of RNA isolation by acid thyocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
25. Farquharson M, Harvie R, McNicol A M. Detection of messenger RNA using a digoxigenin end labelled oligodesoxynucleotide probe. J Clin Pathol 1990; 43: 424-428.
26. Ny T, Leonardsson G, Hsueh J W. Cloning and characterisation of a cDNA for rat tissue-type plasminogen activator. DNA 1988; 7: 671-677.
27. Zelent A, Krust A, Petkovich M, Kastner P, Chambon P. Cloning of murine α and β retinoic acid receptors and a novel receptor y predominantly expressed in skin. Nature 1989; 339: 714-717.
28. Höltke H J, Sagner G, Kessler C, Schmilz G. Sensitive chemiluminescent detection of digoxigenin-labeled nucleic acids: a fast and simple protocol and its applications. Bio Techniques 1992; 12: 104-113.
29. Collen D. Synergism of thrombolytic agents: investigational procedures and clinical potential. Circulation 1988; 77: 731-735.
30. Lopez-Barahona M, Minano M, Mira M, et al. Retinoic acid posttranscriptionally upregulates proteolipid protein gene expression in C6 glioma cells. J Biol Chem 1993; 268: 25617-25623.
31. Niedbala M J, Stein-Picarella M. Role of protein kinase C in tumour necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 1993; 81: 2608-2617.
32. Kooistra T, Opdenberg J P, Toet K, Hendricks H F J, Van den Hoogen R M, Emeis J J. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost 1991; 65: 565-572.
33. Bulens F, Moreau H, De Vriese A, Neues L, Collen D. Hormonal regulation of the expression of fibrinolytic components in HT 1080 fibrosarcoma and endothelial cells. Fibrinolysis & Proteolysis 1997; 11: 57-63.
34. Darrow A L, Rickles R J, Pecorino L T, Strickland S. Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation. Mol Cell Biol 1990; 10: 5883-5893.
35. Heaton J H, Nebes V L, O'Dell L, Morris S M, Gelehrter T D. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 1989; 3: 185-192.
36. Heaton J H, Kathju S, Gelehrter T D. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol Endocrinol 1992; 6: 53-60.
37. Kathju S, Heaton J H, Bruzdzinski C J, Gelehrter T D. Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells. Endocrinology 1994; 135: 1195-1204.
38. Reboul P, George P, Luisot P, Broquet P. Study of retinoic acid effect upon retinoic acid receptor β(RAR-β) in C6 cultured glioma cells. Biochem Mol Biol Intern 1995; 36: 1097-1105.
39. Hu L, Gudas L J. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor α, β and γ mRNAs in F9 teratocarcinoma cells. Mol Cell Biol 1990; 10: 391-396.
40. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393-403.
41. Feng P, Ohlsson M, Ny T. The structure of the TATA-less rat tissue-type plasminogen activator gene. J Biol Chem 1990; 265: 2022-2027.
42. Ohlsson H, Hsueh A J W, Ny T. Hormonal regulation of tissue-type plasminogen activator messenger ribonucleic acid levels in rat granulosa cells: mechanisms of induction by follicule-stimulated hormone and gonadotropin releasing hormone. Mol Endocrinol 1988; 2: 854-861.
43. Kooistra T, Bosma P J, Toet K, et al. Role of protein kinase C and cAMP in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor 1 and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of protooncogenes c-jun and c-fos. Arterioscler Thrombosis 1991; 11: 1042-1052.
44. Jungmann R A, Wang X S, Milkowski D M, Short M L. Glucocorticoids induction of CRE-binding protein isoform mRNAs in rat C6 glioma cells. Nucl Acids Res 1992; 20: 825-829.
45. Lamph W W, Dwarki V J, Ofir R, Montminy M, Verma I M. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc Natl Acad Sci USA 1990; 87: 4320-4324.
46. Montminy M R, Gonzalez G A, Yamamoto K K. Regulation of cAMP-inducible genes by CREB. Trends Neurosci 1990; 13: 184-188.
47. Rangarajan P N, Umesono K, Evans R M. Modulation of glucocorticoide receptor function by protein kinase A. Mol Endocrinol 1992; 6: 1451-1457.